Skip to main content
menu

Jennifer Anolik at the bench

B Cells and Immune Diseases

Defining the role of B cells in systemic autoimmunity has been instrumental in characterizing the impact of B cell depletion (BCD) on the human immune system and establishing B cell targeted therapies. This has been a major advance in the field of immunologic disease with broad implications in rheumatoid arthritis, lupus, diabetes, malignancy, and immune deficiency.

Findings demonstrating a link between the clinical response and the immunologic reconstitution with transitional B cells was the first delineation of a B regulatory cell population in humans, greatly advancing our understanding of BCD therapy and human B cell development pathways. A prominent publication defining new populations of human transitional B cells provided further fundamental insights into the developmental process followed by human B cells, identifying a new population of human transitional B cells. Recent work has elucidated a previously unrecognized cross-talk between the B cell compartment and neutrophil driven α interferon production in the bone marrow in systemic lupus erythematosus (SLE) that alters B cell development and selection, as well as a critical role for B cells in regulation of bone homeostasis in RA.

widget-214fd070-6e8

Jennifer H. Anolik, M.D., Ph.D.

Jennifer H. Anolik, M.D., Ph.D.
Principal Investigator

October 22, 2025
Jennifer Anolik Presents at Upstate Medical Center Symposium

October 20, 2025
National Scleroderma Foundation Rochester Education Forum Held at URMC

September 29, 2025
Jessica Stern, MD Awarded a Mentored Patient-Oriented Research Career Development Award (K23)

May 23, 2025
AIR Research Presented at the 2025 AAI Meeting

May 23, 2025
Dr. Javier Rangel-Moreno Lecturer at the 2025 Course of Biomedicine and Immunology

All News »

Contact Us

  Anolik Lab
601 Elmwood Ave/Box 695
Rochester, NY 14642